Teva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say

Teva Pharmaceutical Industries Ltd. (TEVA) reported $4.23 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 5.1%. EPS of$ 0.71 for the same period compares to $1.00 a year ago.The reported revenue represents a surprise of +3.13% over the Zacks Consensus Estimate of$ 4.1 billion. With the consensus EPS estimate being $0.70, the EPS surprise was +1.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street exp ...